StonvexLoading…
StonvexStonvexStonvexCore line items from NJR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-09-30 | Annual 2024 2024-09-30 | Annual 2023 2023-09-30 | Annual 2022 2022-09-30 |
|---|---|---|---|---|
Revenue | $1.35B | $1.23B | $1.11B | $1.20B |
Operating Income | $508.87M | $458.10M | $407.00M | $406.48M |
Net Income | $335.63M | $289.77M | $264.72M | $274.92M |
EPS (Diluted) | $3.33 | $2.92 | $2.71 | $2.85 |
Total Assets | $7.58B | $6.98B | $6.54B | $6.26B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $591.00K | $1.02M | $954.00K | $1.11M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 100.48M | 99.46M | 97.58M | 96.25M |